BANK OF NEW YORK MELLON CORP – Vertex Pharmaceuticals Incorporated Transaction History
BANK OF NEW YORK MELLON CORP portfolio value:
$602.66M
portfolio value
BANK OF NEW YORK MELLON CORP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.80% | -16.83K shares | 11.38M | $289.54 | 2.08M |
| Q2 2022 | share | Increase | +4.76% | 95.43K shares | 68.59M | $281.79 | 2.09M |
| Q1 2022 | share | Decrease | -2.91% | -59.94K shares | 69.69M | $260.97 | 2.00M |
| Q4 2021 | share | Decrease | -1.24% | -25.98K shares | 74.10M | $222.45 | 2.06M |
| Q3 2021 | share | Decrease | -1.23% | -25.93K shares | -47.50M | $181.39 | 2.08M |
| Q2 2021 | share | Decrease | -1.58% | -33.94K shares | -35.33M | $201.63 | 2.11M |
| Q1 2021 | share | Decrease | -5.84% | -133.22K shares | -77.57M | $214.89 | 2.14M |
| Q4 2020 | share | Decrease | -12.14% | -315.29K shares | -167.44M | $236.34 | 2.28M |
| Q3 2020 | share | Increase | +3.47% | 87.01K shares | -21.98M | $272.12 | 2.59M |
| Q2 2020 | share | Increase | +0.70% | 17.54K shares | 135.60M | $290.31 | 2.51M |
| Q1 2020 | share | Decrease | -0.67% | -16.77K shares | 43.68M | $237.95 | 2.49M |
| Q4 2019 | share | Decrease | -2.80% | -72.19K shares | 112.05M | $218.95 | 2.50M |
| Q3 2019 | share | Increase | +0.13% | 3.44K shares | -35.40M | $169.42 | 2.58M |
| Q2 2019 | share | Increase | +12.97% | 296.06K shares | 52.99M | $183.38 | 2.57M |
| Q1 2019 | share | Increase | +3.49% | 76.93K shares | 54.37M | $183.95 | 2.28M |
| Q4 2018 | share | Decrease | -5.36% | -124.88K shares | -83.67M | $165.71 | 2.20M |
| Q3 2018 | share | Decrease | -0.02% | -556 shares | 52.98M | $192.74 | 2.33M |
| Q2 2018 | share | Decrease | -0.91% | -21.44K shares | 12.77M | $169.96 | 2.33M |
| Q1 2018 | share | Increase | +16.46% | 332.47K shares | 80.68M | $162.98 | 2.35M |
| Q4 2017 | share | Increase | +1.26% | 25.15K shares | -577K | $149.86 | 2.01M |
| Q3 2017 | share | Increase | +0.63% | 12.45K shares | 47.81M | $152.04 | 1.99M |
| Q2 2017 | share | Decrease | -4.91% | -102.27K shares | 27.50M | $128.87 | 1.98M |
| Q1 2017 | share | Increase | +0.27% | 5.61K shares | 74.77M | $109.35 | 2.08M |
| Q4 2016 | share | Decrease | -31.53% | -957.09K shares | -111.61M | $73.67 | 2.07M |
| Q3 2016 | share | Increase | +0.44% | 13.27K shares | 4.75M | $87.21 | 3.03M |
| Q2 2016 | share | Decrease | -4.54% | -143.60K shares | 8.32M | $86.02 | 3.02M |
| Q1 2016 | share | Decrease | -12.02% | -432.4K shares | -201.12M | $79.49 | 3.16M |